| controls | all patients | stage of cirrhosis | |||
---|---|---|---|---|---|---|
no cirrh. | Child A | Child B | Child C | |||
n | 41 | 71 | 23 | 21 | 13 | 14 |
sex male/ female n | 20/21 | 37/34 | 11/12 | 8/13 | 8/5 | 10/4 |
age yrs | 35 | 54 | 43 | 61 | 63 | 53 |
median (range) | (18–65) | (17–74) | (17–64) | (30–74) | (28–74) | (34–73) |
disease etiology n | n.a. | Â | Â | Â | Â | Â |
 virus hepatitis |  | 24 | 11 | 8 | 5 | 0 |
 biliary/autoimmune |  | 8 | 2 | 4 | 1 | 1 |
 alcohol |  | 21 | 3 | 5 | 3 | 10 |
 other origin |  | 18 | 7 | 4 | 4 | 3 |
MELD score | n.a. | n.a. | n.a. | 8 | 11 | 17 |
median (range) | (6–17) | (7–16) | (12–28) | |||
ALT U/L | 19 | 41 | 64 | 34 | 36 | 29 |
median (range) | (5–54) | (7–568) | (15–568) | (8–188) | (7–92) | (14–261) |
bilirubin mg/dL | n.a. | 1.3 | 0.7 | 0.9 | 1.6 | 5.1 |
median (range) | (0.2-12.5) | (0.4-8.7) | (0.2-8.9) | (0.2-9.0) | (1.8-12.5) | |
albumin mg/dL | n.a. | 38 | 45 | 40 | 27 | 27 |
median (range) | (12–50) | (40–50) | (30–43) | (12–38) | (22–31) | |
international normalized | n.a. | 1.07 | 0.98 | 1.06 | 1.20 | 1.43 |
ratio median (range) | (0.92-1.69) | (0.93-1.12) | (0.92-1.32) | (0.99-1.39) | (1.18-1.69) | |
hyaluronic acid μg/l | n.a. | 190 | 28 | 205 | 305 | 800 |
median (range) | (10–800) | (10–210) | (36–800) | (140–800) | (190–800) | |
procollagen-III-peptide | 584 | 1135 | 973 | 990 | 1710 | 2500 |
median (range) μg/l | (157–1160) | (470–6560) | (470–1750) | (589–1930) | (639–2630) | (1010–6560) |
creatinine mg/dL | 0.7 | 0.7 | 0.7 | 0.7 | 0.6 | 0.8 |
median (range) | (0.6-0.9) | (0.3-2.4) | (0.4-1.0) | (0.4-1.9) | (0.4-1.8) | (0.3-2.4) |
cystatin C mg/L | n.a. | 0.98 | 0.80 | 1.01 | 1.20 | 1.46 |
median (range) | (0.40-2.81) | (0.40-1.16) | (0.69-2.81) | (0.74-2.78) | (0.80-2.41) | |
GFR [cyst. C] ml/min | n.a. | 88 | 123 | 83 | 64 | 45 |
median (range) | (15–395) | (66–395) | (15–158) | (15–140) | (19–123) | |
total monocytes x106/L | 416 | 490 | 419 | 426 | 477 | 816 |
median (range) | (165–852) | (70–2208) | (70–860) | (296–1332) | (162–2208) | (294–1180) |
CD14++CD16- monocytes | 386 | 442 | 384 | 387 | 425 | 714 |
x106/L median (range) | (155–748) | (65–2101) | (65–807) | (250–1155) | (142–2101) | (257–1089) |
CD14+CD16+ monocytes | 32.4 | 46 | 40 | 45 | 67 | 92 |
x106/L median (range) | (10–108) | (4.6-175) | (4.6-158) | (26–175) | (18–135) | (6.4-153) |
sIL-2R kU/L | 444 | 818 | 374 | 764 | 1101 | 1029 |
median (range) | (14–1193) | (39–3976) | (204–1795) | (39–3976) | (317–2494) | (370–3350) |